Intel®, Cancer Research UK and Imperial College London Celebrate Supercomputing Successes in the UK

IntelToday Cancer Research UK and Imperial College London outlined the fundamental importance of High Performance Computing to their future science and research strategies. The two organisations described how Intel® High Performance Computing (HPC) solutions are enabling them to drive forward their research, which will lead to future scientific breakthroughs.

Imperial College London currently spends over £1,000 000 on its HPC programme. "HPC allows us to simulate events that would be impossible or very difficult to measure experimentally," stated Simon Burbidge, High Performance Computing Co-ordination Manager at Imperial College London. "For example, it is very difficult to reach the kind of temperatures such as those within the sun or plasmas in the real world, but by using HPC we can perform simulations to predict the results and thus tune the experiments. Another area of research at Imperial College London is using HPC to model blood flows in human arteries, to drive insights into the conditions leading to heart and circulatory disease. It is also helping us to do better research at lower cost, for example where simulations can replace some of the wind tunnel tests used in automobile design."

Peter McCallum, Head of IT & Scientific Computing at Cancer Research UK's Cambridge Research Institute described the benefits that HPC has brought to his organisation, "Through HPC we can effectively sequence a human’s whole DNA. Medical units in hospitals may soon need HPC access to enable them to track disease. We believe that in the future there will be local access to HPC with a local scientific computing team in all biological science organisations. What happened in physics and chemistry twenty years ago is now happening in biology."

Sean McGuire, Director Strategic Government Programs HPC EMEA at Intel stated, "HPC is an added direction for Intel. Through the Intel® Many Integrated Core (MIC) architecture we can achieve more compute power than would have been possible previously. It is an architecture that is designed for highly parallel workloads. We believe that it is an indication of where computing is going."

Robert Maskell, Head of HPC for Intel in the UK added, "Analysts have been telling us for a while that HPC is now mainstream, I think it is even further along the curve than that. It is pervasive. It is difficult to think of any manmade object which has not been created without being touched by HPC during the design process. HPC has become one of the fundamental building blocks for science. Researchers are being deluged by floods of data. The question they are asking is how can they cost effectively process and securely store that data. We believe Intel's Xeon range of processors deliver the energy-efficient performance that will allow researchers to draw ever quicker results and conclusions from their science."

Intel Corporation announced plans earlier this year to deliver new products based on the Intel® Many Integrated Core (MIC) architecture that will create platforms running at trillions of calculations per second, while also retaining the benefits of standard Intel processors. Targeting high-performance computing segments such as exploration, scientific research and financial or climate simulation, the first product, codenamed "Knights Corner", will be made on Intel's 22-nanometer manufacturing (nm) process - using transistor structures as small as 22 billionths of a meter - and will use Moore's Law to scale to more than 50 Intel processing cores on a single chip. While the vast majority of workloads will still run best on award-winning Intel® Xeon® processors, Intel® MIC architecture will help accelerate select highly parallel applications.

Industry design and development kits codenamed "Knights Ferry" are currently shipping to select developers, and beginning in the second half of 2010, Intel will expand the program to deliver an extensive range of developer tools for Intel MIC architecture.

Related news articles:

About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com.

Most Popular Now

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...